共 51 条
[1]
Goudet P(2010)Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients World J Surg 34 249-255
[2]
Murat A(1998)Lethality of multiple endocrine neoplasia type I World J Surg 22 581-586
[3]
Binquet C(2012)Endocrine Society. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1) J Clin Endocrinol Metab 97 2990-3011
[4]
Cardot-Bauters C(2012)Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des tumeurs endocrines database Eur J Endocrinol 166 269-279
[5]
Costa A(2017)Aggressive adrenal carcinoma in a young patient with multiple endocrine neoplasia 1 syndrome Med Clin (Barc) 149 463-1207
[6]
Ruszniewski P(2009)Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN 1 from the GTE (Groupe des Tumeurs Endocrines) World J Surg 33 1197-716
[7]
Doherty GM(2017)Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: a single-centre study, systematic review and meta-analysis Clin Endocrinol (Oxf) 87 706-2090
[8]
Olson JA(2017)MEN1-dependent breast cancer: indication for early screening? results from the dutch MEN1 study group J Clin Endocrinol Metab 102 2083-undefined
[9]
Frisella MM(2019)Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1 Endocrinol Diabetes Metab Case Rep 19 0040-undefined
[10]
Lairmore TC(undefined)undefined undefined undefined undefined-undefined